Ironwood is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines targeting important therapeutic needs. Our goal is to build the next great pharmaceutical company—an outstanding business that will thrive and endure well beyond our lifetimes and generate substantial returns for our shareholders.

Press Releases

08.05.2010
Ironwood Pharmaceuticals Provides Second Quarter 2010 Investor Update

08.02.2010
Ironwood Pharmaceuticals Announces Second Quarter 2010 Investor Update Call

07.28.2010
Ironwood Pharmaceuticals Announces Upcoming Presentation at Wedbush Life Sciences MAC Best Ideas 2010

05.26.2010
Ironwood Pharmaceuticals Announces Participation in J.P. Morgan Biotech CEO/CFO Conference Call

05.11.2010
Ironwood Pharmaceuticals Provides First Quarter 2010 Investor Update

View all releases »




Current Prices
Quotes delayed 20 minutes
IRWD NASDAQ $9.27   - 0.02


Receive Email Notifications
Investor FAQs
Audio Archive


View Ironwood Historical Stock
Prices Here


View our conference calendar and upcoming events



2009 10-K | 04.27.2010
View/Download PDF Version



Ironwood IR contact
Susan Brady
Corporate Communications
T 617.621.8304
E ir@ironwoodpharma.com

Auditors
Ernst & Young
200 Clarendon Street
Boston, MA 02116
T 617.266.2000

Transfer agent
Computershare Investor Services
P.O.Box 43078
Providence, RI 02940
T 800.662.7232
www.computershare.com